Abstract
WehaveexaminedtheexpressionofPit-1messengerRNA(mRNA) splice variants in the nonhuman primate pituitary and in rhesus and human placenta. Full-length complementary DNAs (cDNAs) repre- senting Pit-1 and the Pit-1bsplice variants were cloned from a rhesus monkey pituitary cDNA library and were readily detectable by RT- PCR with rhesus pituitary gland RNA. The Pit-1T variant previously reported in mouse pituitary tumor cell lines was not detectable in normal rhesus pituitary tissue, although two novel splice variants were detected. A cDNA approximating the rat Pit-1 D4 variant was cloned but coded for a truncated and presumably nonfunctional pro- tein. Only by using a nested RT-PCR approach were Pit-1 and Pit-1b variants consistently detectable in both human and rhesus placental tissue. The Pit-1b variant mRNA was not detectable in JEG-3 cho- riocarcinoma cells unless the cells were stimulated with 8-Br-cAMP. Immunoblot studies with nuclear extracts from primary rhesus syn- cytiotrophoblast cultures or JEG-3 choriocarcinoma cells indicated that although mRNA levels were very low, Pit-1 protein was detect- able in differentiated cytotrophoblasts, and levels increased after treatment with 8-Br-cAMP. Two major species of Pit-1 protein were detected that corresponded to the two major bands in rat pituitary GH3 cell nuclear extracts. Low levels of slightly larger bands also were seen, which may represent Pit-1b protein or phosphorylated species. We conclude that Pit-1 splice variants expressed in the pri- mate pituitary gland differ from those in the rodent gland and that the Pit-1 and Pit-1b mRNAs expressed in the placenta give rise to a pattern of protein expression similar to that seen in pituitary cells, which is inducible by treatment with 8-Br-cAMP. (J Clin Endocrinol Metab 82: 800-807, 1997)